文献速递临床试验与 GCP真实世界研究与卫生经济

药师教育干预对类风湿关节炎患者疾病知识、康复与用药依从性、治疗直接成本、健康相关生活质量及满意度的影响:随机对照试验研究方案

Impact of pharmacist educational intervention on disease knowledge, rehabilitation and medication adherence, treatment-induced direct cost, health-related quality of life and satisfaction in patients with rheumatoid arthritis: study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2019-08-09

本研究为在巴基斯坦卡拉奇门诊风湿科开展的随机、单盲、两臂对照试验,计划纳入确诊类风湿关节炎患者并1:1随机分为常规护理组与药学服务组,比较基线与第12周疾病知识、用药依从性及康复/物理治疗变化,并评估直接成本、健康相关生活质量及对药师咨询的满意度。

要点

  • 研究计划在3个月内纳入确诊类风湿关节炎患者,按1:1随机分为常规护理组与药学服务组。
  • 主要结局为基线(第0周)至随访(第12周)疾病知识、用药依从性及康复/物理治疗平均评分变化。
  • 次要结局包括治疗直接成本、健康相关生活质量及患者对药师咨询满意度的平均变化。

核心结论

  • 本试验旨在评估药师干预改善类风湿关节炎患者疾病知识、治疗依从性、健康相关生活质量及治疗直接成本的效果,并记录患者对药师咨询的满意度作为质量控制措施。
  • 作者认为这是一项新颖的研究,其结果可为巴基斯坦该患者人群未来照护提供基础,并将发表于同行评议期刊。

研究设计与样本

  • 随机、单盲、两臂、对照试验,在巴基斯坦卡拉奇门诊风湿科就诊的类风湿关节炎患者中开展。
  • 计划在3个月内纳入确诊类风湿关节炎患者,签署书面知情同意后通过计算机生成列表按1:1随机分为常规护理组或药学服务组。
  • 研究在3个月内进行两次患者访视。

关键数值与推荐

  • 主要结局为基线(第0周)与随访(第12周)疾病知识、用药依从性及康复/物理治疗平均评分的变化。
  • 次要结局为治疗直接成本、健康相关生活质量及患者对药师咨询满意度的平均变化。

临床怎么用

  • 干预组患者接受药师提供的干预,对照组患者接受常规护理。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The objective of this study is to evaluate the effectiveness of pharmacist intervention in improving disease knowledge, adherence to treatment, health-related quality of life (HRQoL) and direct cost of treatment. The study also documents patient satisfaction with pharmacist counselling as a quality control measure. METHODS/DESIGN: This is a randomized, single-blind, two-arm, controlled trial in patients with rheumatoid arthritis visiting outpatient rheumatology clinics in Karachi, Pakistan. We will enroll patients with established diagnosis of rheumatoid arthritis over 3 months. The patients would be randomized through a computer-generated list into the control group, i.e., usual care or into the intervention group, i.e., pharmaceutical care, in a ratio of 1:1, after providing signed written consent. The study will take place in two patient-visits over the course of 3 months. Patients in the intervention group would receive intervention from the pharmacist while those in the control group will receive usual care. Primary outcomes include change in mean score from baseline (week 0) and at follow up (week 12) in disease knowledge, adherence to medications and rehabilitation/physical therapy. The secondary outcomes include change in the mean direct cost of treatment, HRQoL and patient satisfaction with pharmacist counselling. DISCUSSION: This is a novel study that evaluates the role of the pharmacist in improving treatment outcomes in patients with rheumatoid arthritis. The results of this trial could set the foundation for future delivery of care for this patient population in Pakistan. The results of this trial would be published in a peer-reviewed journal. TRIAL REGISTRATION: ClinicalTrials.gov, NCT03827148 . Registered on February 2019.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Naqvi AA, Hassali MA, Naqvi SBS, et al. Impact of pharmacist educational intervention on disease knowledge, rehabilitation and medication adherence, treatment-induced direct cost, health-related quality of life and satisfaction in patients with rheumatoid arthritis: study protocol for a randomized controlled trial. Trials. 2019. PMID: 31399128. doi:10.1186/s13063-019-3540-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。